Nextbio Research Private Limited - Due diligence report

A 360° intelligence report on Nextbio: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

2016-08-02 Bangalore, Karnataka Active Unlisted Active Compliant
Share
View plans Plan
NR Nextbio Research Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Nextbio — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Nextbio is assessed as Moderate with a Trust Score of 74/100. Nextbio is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 13 Jul 2026 from the latest processed filings. Nextbio Research Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: EPFO.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
UMESH ANANTHA PADMANABHA BISILE 01234567 Director 01/04/2018 6 yrs Approved
NAGENDRA NAGASUNDAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
The Sunseeker Trust
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
The Sunseeker Trust Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 90
Growth signals & trust indicators
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2021
Share transfer (FY 2021)
200.00000000 shares to UMESH ANANTHA PADMANABHA BISILE
31 Dec 2019
Director ceased
SHUBA GIRISH
23 Sep 2019
Securities allotted
471220 Equity Shares - 70.68 Lakh raised
31 Dec 2018
Securities allotted
162591 Equity Shares - 24.39 Lakh raised
02 May 2017
Director appointed
NAGENDRA NAGASUNDAR (Additional Director)
29 Mar 2017
Securities allotted
1995119 Equity Shares - 2.00 cr raised
10 Feb 2017
Securities allotted
1995119 Equity Shares - 2.00 cr raised
02 Aug 2016
Incorporated
Registered with Roc Bangalore
Director appointed
UMESH ANANTHA PADMANABHA BISILE (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vertical Technology Solutions Private Limited U72900MH2019PTC319383 Mumbai, Maharashtra, India
Mark Engineers (India) Private Limited U99999MH1993PTC129241 Panvel, Maharashtra, India
Tri-Star Computer Services Private Limited U72900CT1991PTC006340 Raipur, Chattisgarh, India
Ganesai Consultancy Services Private Limited U67190MH1998PTC117509 Mumbai, Maharashtra, India
Anagha Technologies Private Limited U72900KA2007PTC041463 Mysore, Karnataka, India
Doctorquick U72900KA2017PTC108133 Bangalore, Karnataka, India
Akshay Renewable Energy Private Limited U40108DL1997PTC086637 New Delhi, Delhi, India
Icrx Life Sciences Private Limited U74999GJ2019PTC106264 Anand, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Nextbio before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Nextbio: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Nextbio - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Nextbio pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Nextbio - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Nextbio an active company?

Nextbio has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Nextbio financially healthy?

Nextbio has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Nextbio?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Nextbio?

The ultimate holding entity is The Sunseeker Trust. 2 active director(s) are on record.

Does Nextbio have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Nextbio up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Nextbio?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.